Publications by authors named "Tim Henkel"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2,153

Total Likes

350

Extended Reach

2,541,864

Social Features

127
C
Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Florian M Wagenlehner, Leanne B Gasink, Paul C McGovern, Greg Moeck, Patrick McLeroth, MaryBeth Dorr, Aaron Dane, Tim Henkel,

February 2024

Videos about Article: user user

2 2 125 2 28

View All Article and Social Media Activity
P
Plasma and intrapulmonary pharmacokinetics of cefepime and taniborbactam in healthy adult participants.
Keith A Rodvold, Mark H Gotfried, Philip Sabato, Tim Henkel, Paul C McGovern

Antimicrob Agents Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient outcomes by baseline pathogen resistance phenotype and genotype in CERTAIN-1, a Phase 3 study of cefepime-taniborbactam versus meropenem in adults with complicated urinary tract infection.
Greg Moeck, Leanne B Gasink, Rodrigo E Mendes, Leah N Woosley, MaryBeth Dorr, Tim Henkel

Antimicrob Agents Chemother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal Impairment.
James A Dowell, Thomas C Marbury, William B Smith, Tim Henkel

Antimicrob Agents Chemother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics in Human Volunteers of Taniborbactam (VNRX-5133), a Novel Intravenous β-Lactamase Inhibitor.
James A Dowell, Daniel Dickerson, Tim Henkel

Antimicrob Agents Chemother· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel targeted therapies for eosinophilic disorders.
Michael E Wechsler, Patricia C Fulkerson, Bruce S Bochner, Gail M Gauvreau, Gerald J Gleich, Tim Henkel

J Allergy Clin Immunol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens.
Issam Raad, Rabih Darouiche, Jose Vazquez, Arnold Lentnek, Ray Hachem, Tim Henkel

Clin Infect Dis· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of anidulafungin, an echinocandin antifungal.
James A Dowell, William Knebel, Tom Ludden, Marty Stogniew, David Krause, Tim Henkel

J Clin Pharmacol· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections.
Elyse Seltzer, Mary Beth Dorr, Beth P Goldstein, Marc Perry, James A Dowell, Tim Henkel

Clin Infect Dis· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis